You are here: Home » International » News » Economy
Business Standard

Glycine from India, China hurting US biz, anti-dumping duty to be issued

The United States International Trade Commission (USITC) determined that glycine was sold in the US at less than fair value and imports that are subsidised by the governments of China and India.

Topics
Trade  |  Dumping  |  America

Press Trust of India  |  Washington 

pharma, chemicals
Representative Image

Import of glycine from India, and is hurting the US industry as the product is sold at less than fair value in America, a federal body has claimed.

The Commission (USITC) said it had determined the US industry was materially injured by imports of glycine from and

It also determined that glycine was sold in the US at less than fair value and imports that are subsidised by the governments of and

As a result of the USITC's affirmative determinations, US Department of Commerce will issue antidumping duty orders on imports of this product from and and countervailing duty orders on imports of it from and India, an official statement said on Wednesday.

USUITC Chairman David Johanson and Commissioners Irving Williamson, Meredith Broadbent, Rhonda Schmidtlein and Jason Kearns voted in the affirmative, according to an official statement.

US import of glycine from China, India, and Japan in 2017 was valued USD 18.6 million. Its import from was USD 4.6 million and from all other sources was USD 480,000.

China, India, Japan and are the leading source of import of glycine.

Glycine, also known as aminoacetic acid, is a nonessential amino acid. The organic chemical is produced naturally by humans and other organisms as a building block for proteins.

Commercial production of glycine uses traditional chemical synthesis. Glycine is commonly sold in its dry form as a white, free flowing powder.

Available in various grades, glycine is used in industrial applications, as well as pharmaceutical and food applications.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, May 30 2019. 08:05 IST
RECOMMENDED FOR YOU
.